Before the advent of the television remote control, if you wanted to change the channel or adjust the volume, you were forced to get up from the couch, trudge across the room, and manually turn a knob ...
First Horizon Chairman, President, and CEO Bryan Jordan joins 'Mad Money' host Jim Cramer to talk quarterly results, the housing market, and more. Got a confidential news tip? We want to hear from you ...
Jim Clyburn discusses the role of race in politics in America’s past and present. Rep. Jim Clyburn (D-S.C.) discusses the role of race in politics in America’s past and present, his warning for ...
Former head coach Gary Pinkel has watched from afar as one of his top players, Jim Harding, went from being a team captain and four-year starter at Toledo to a respected offensive line coach. Harding, ...
Jim Pat Wade, 87, of Alamogordo, New Mexico, passed away peacefully on December 20, 2025. Born on November 13, 1938, in Carlsbad, New Mexico, Jim lived a full life grounded in family, faith, and hard ...
The Dallas Cowboys have requested to interview three candidates for their defensive coordinator opening, according to a report from ESPN’s Todd Archer. The Cowboys are in line to speak with Broncos ...
WILSON, N.C. (WTVD) -- Loved ones and friends of former North Carolina Gov. Jim Hunt gathered at First Presbyterian Church in Wilson on Friday afternoon to say their final goodbyes. Hunt died last ...
Syracuse, N.Y. -- The Onondaga County Water Authority will spend the weekend getting ready to repair a ruptured transmission line on Monday as work crews and equipment stream in from as far as Texas.
And all that love? Cleary reciprocated by Curtis, a wellness coach and hypnotherapist she began dating earlier this year. “Hypnotism is one of the many things that he does,” Aniston raved to Elle in ...
The United Nations rarely moves fast on disarmament. This year, though, it did something unusual. On November 6, the General Assembly’s First Committee, where states debate over questions of ...
In the last Fierce Pharma Asia weekly news roundup of 2025, Daiichi Sankyo scored a key FDA approval for AstraZeneca-partnered Enhertu in first-line HER2-positive breast cancer but paused a phase 3 ...
After AstraZeneca and Daiichi Sankyo made waves in June with eye-opening results for Enhertu in a combination treatment for a particular type of breast cancer, the companies have scored an FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results